Vitamin D Zinc Fever

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by Assaf-Harofeh Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT01080950
First received: March 3, 2010
Last updated: March 4, 2010
Last verified: March 2010
  Purpose

Zinc and vitamin d deficiency are associated with a state of inflammation/atherosclerosis.

There are studies demonstrating an association between vitamin d deficiency and respiratory illnesses.

Both zinc and vitamin d are associated with oxidative stress and inflammation.


Condition
Sepsis
Fever
Vitamin D

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Vitamin d and Zinc Levels in Patients With Fever

Resource links provided by NLM:


Further study details as provided by Assaf-Harofeh Medical Center:

Biospecimen Retention:   Samples Without DNA

blood drawn for vitamin d will be freezed and stored until all samples have been collected and only than will it be analyzed.


Estimated Enrollment: 200
Study Start Date: March 2010
Estimated Study Completion Date: March 2011
Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
fever zinc vit. d
patients with fever but without sepsis
sepsis zinc vit. d
patients with sepsis

Detailed Description:

Both vit. d and zinc share anti inflammatory and anti oxidative actions. vit. d deficiency is associated with an increase in serum levels of proinflammatory cytokines and decreased levels of anti inflammatory cytokines.

there are reports concerning the association of vit. d deficiency with infections.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

patients hospitalized with fever and or sepsis.

Criteria

Inclusion Criteria:

  • age>18 years

Exclusion Criteria:

  • CCT<90
  • taking calcium
  • hyper/hypoparathyroidism
  • active malignancy.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01080950

Contacts
Contact: renana shor, md 97289779240 renanashor@yahoo.com

Locations
Israel
Assaf Harofeh Mc Not yet recruiting
Zerifin, Israel
Principal Investigator: renana shor, md         
Sponsors and Collaborators
Assaf-Harofeh Medical Center
  More Information

No publications provided

Responsible Party: renana shor md, Assaf - Harofeh MC
ClinicalTrials.gov Identifier: NCT01080950     History of Changes
Other Study ID Numbers: vitamin d zinc and fever
Study First Received: March 3, 2010
Last Updated: March 4, 2010
Health Authority: Israel: Ministry of Health

Keywords provided by Assaf-Harofeh Medical Center:
zinc
sepsis
fever
vitamin d

Additional relevant MeSH terms:
Fever
Body Temperature Changes
Signs and Symptoms
Vitamin D
Vitamins
Bone Density Conservation Agents
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on October 30, 2014